Fraunhofer IZI and Nomad Bioscience extend and broaden collaboration
The Fraunhofer Institute for Cell Therapy and Immunology IZI and Nomad Bioscience GmbH have extended and expanded their collaboration. In July 2020, both had concluded an initial research and development agreement. The Fraunhofer IZI Molecular Drug Biochemistry and Therapeutics Development Branch in Halle (Saale) supports the Munich-based company in the identification and preclinical development of pharmaceutical product candidates, in particular through assay development, pharmacological and toxicological studies, and the development of preclinical models.
For more info see the press release of Nomad Bioscience GmbH
Press release on the conclusion of the 2020 research and development agreement